Increased clearance of cortisol by 5β-reductase in a subgroup of women with adrenal hyperandrogenism in polycystic ovary syndrome

Journal of Endocrinological Investigation

Volumn 32, Issue 3, 2009, Pages 210-218

  Gambineri, A ^a   Forlani, G ^a   Munarini, A ^a   Tomassoni, F ^a   Cognigni, G E ^b   Ciampaglia, W ^b   Pagotto, U ^a   Walker, B R ^c   Pasquali, R ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Day Surgery Center   (Italy)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

5 reductase; 5 reductase; Adrenal hyperandrogenism; Obesity; Polycystic ovary syndrome

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; ANDROSTANOLONE; ANDROSTENEDIONE; CORTICOTROPIN; HYDROCORTISONE; PRASTERONE; STEROID 5BETA REDUCTASE; TESTOSTERONE; TETRACOSACTIDE;

ADULT; ANDROGEN RELEASE; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; BODY FAT; BODY WEIGHT; CONTROLLED STUDY; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERANDROGENISM; MAJOR CLINICAL STUDY; OBESITY; OVARY POLYCYSTIC DISEASE; STEROIDOGENESIS; TESTOSTERONE BLOOD LEVEL;

EID: 67651249649     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03346454     Document Type: Article

References (40)

1. Carmina E, Koyama T, Chang L, Stanczyk FZ, Lobo RA. Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? Am J Obstet Gynecol 1992, 167: 1807-1812
2. Wild RA, Umstot ES, Andersen RN, Ranney GB, Givens JR. Androgen parameters and their correlation with body weight in one hundred thirty-eight women thought to have hyperandrogenism. Am J Obstet Gynecol 1983, 146: 602-605
3. Hoffman DI, Klove K, Lobo RA. The prevalence and significance of elevated dehydroepiandrosterone sulfate levels in anovulatory women. Fertil Steril 1984, 42: 76-81. (Pubitemid 14086154)
4. Azziz R, Black V, Hines GA, Fox LM, Boots LR. Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis. J Clin Endocrinol Metab 1998, 83: 2317-2323 (Pubitemid 28503021)
5. Walker BR. Activation of the hypothalamic-pituitary-adrenal axis: cause or consequence? Growth Horm IGF Res 2001, 11 (Suppl A): S91-5.
6. Seckl JR, Walker BR. Minireview: 11beta-hydroxysteroid dehydrogenase type 1 - a tissue-specific amplifier of glucocorticoid action. Endocrinology 2001, 142: 1371-1376 (Pubitemid 32299662)
7. Russell DW, Wilson JD. Steroid 5α-reductase: two genes/two enzymes. Ann Rev Biochem 1994, 63: 25-61. (Pubitemid 2109098)
8. Charbonneau A, The VL. Genomic organization of a human 5beta-reductase and its pseudogene and substrate selectivity of the expressed enzyme. Bioch Bioph Acta 2001, 1517: 228-235
9. Rodin A, Thakkar H, Taylor N, Clayton R. Hyperandrogenism in polycystic ovary syndrome: evidence of dysregulation of 11β-hydroxysteroid dehydrogenase. N Engl J Med 1994, 330: 460-465 (Pubitemid 24058934)
10. Stewart PM, Shackleton CH, Beastall GH, Edwards CR. 5α-reductase activity in polycystic ovary syndrome. Lancet 1990, 335: 431-433 (Pubitemid 20054649)
11. Chin D, Shackleton C, Prasad VK, et al. Increased 5alpha-reductase and normal 11beta-hydroxysteroid dehydrogenase metabolism of C19 and C21 steroids in a young population with polycystic ovarian syndrome. J Pediatr Endocrinol Metab 2000, 13: 253-259 (Pubitemid 30163749)
12. Tsilchorozidou T, Honour JW, Conway GS. Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5α-reduction but not the elevated adrenal steroid production rates. J Clin Endocrinol Metab 2003, 88: 5907-5913 (Pubitemid 38033071)
13. Rask E, Olsson T, Söderberg S, et al. Tissue-specific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab 2001, 86: 1418-1421 (Pubitemid 32323037)
14. Stewart PM, Boulton A, Kumar S, Clark PM, Shackleton CH. Cortisol metabolism in human obesity: impaired cortisone-→cortisol conversion in subjects with central adiposity. J Clin Endocrinol Metab 1999, 84: 1022-1027 (Pubitemid 29138237)
15. Andrew R, Phillips DI, Walker BR. Obesity and gender influence cortisol secretion and metabolism in man. J Clin Endocrinol Metab 1998, 83: 1806-1809 (Pubitemid 28501063)
16. Nestler JE, Jakubowicz DJ, Evans WS, Pasquali R. Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med 1998, 338: 1876-1880 (Pubitemid 28287859)
17. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961, 21: 1440-1447
18. Gambineri A, Pelusi C, Genghini S, et al. Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 2004, 60: 241-249 (Pubitemid 38200907)
19. The Rotterdam ESHRE/ASMR-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004, 19: 41-47
20. Pasquali R, Gambineri A, Biscotti D, et al. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. J Clin Endocrinol Metab 2000, 85: 2767-2774 (Pubitemid 32269149)
21. WHO Preventing and Managing the Global Epidemic. Report of a WHO consultation on obesity. WHO/NUT/NCD/98.1. 1997 World Health Organization, Geneva.
22. Gambineri A, Pelusi C, Manicardi E, et al. Glucose intolerance in a large cohort of mediterranean women with polycystic ovary syndrome: phenotype and associated factors. Diabetes 2004, 53: 2353-2358 (Pubitemid 39145589)
23. Pasquali R, Gambineri A, Anconetani B, et al. The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment. Clin Endocrinol (Oxf) 1999, 50: 517-527 (Pubitemid 29193237)
24. Vicennati V, Pasquali R. Abnormalities of the hypothalamic-pituitary- adrenal axis in nondepressed women with abdominal obesity and relations with insulin resistance: evidence for a central and peripheral alteration. J Clin Endocrinol Metab 2000, 85: 4093-4098 (Pubitemid 32055358)
25. Boschi S, De lasio R, Mesini P, et al. Measurement of steroid hormones in plasma by isocratic high performance liquid chromatography coupled to radioimmunoassay. Clin Chim Acta 1994, 231: 107-113
26. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999, 84: 3666-3672 (Pubitemid 30645223)
27. Mather KJ, Hunt AE, Steinberg HO, et al. Repeatability characteristic of simple indices of insulin resistance: implications for research applications. J Clin Endocrinol Metab 2001, 86: 5457-5464 (Pubitemid 33070275)
28. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing. Diabetes Care 1999, 22: 1462-1470
29. Best R, Walker BR. Additional value of measurement of urinary cortisone and unconjugated cortisol metabolites in assessing the activity of 11β-hydroxysteroid dehydrogenase in vivo. Clin Endocrinol (Oxf) 1997, 47: 231-236 (Pubitemid 27359904)
30. Zumoff B, Fukushima DK, Hellman L. Intercomparison of four methods for measuring cortisol production. J Clin Endocrinol Metab 1974, 38: 169-175
31. Ulick S, Tedde R, Wang JZ. Defective ring A reduction of cortisol as the major metabolic error in the syndrome of apparent mineralcorticoid excess. J Clin Endocrinol Metab 1992, 74: 593-599
32. Palermo M, Shackleton CHL, Mantero F, Stewart PM. Urinary free cortisone and the assessment of 11β-hydroxysteroid dehydrogenase activity in man. Clin Endocrinol (Oxf) 1996, 45: 605-611 (Pubitemid 26411362)
33. Burger HG. Androgen production in women. Fertil Steril 2002, 77 (Suppl 4): S3-5.
34. Fassnacht M, Schlenz N, Schneider SB, Wudy SA, Allolio B, Arlt W. Beyond adrenal and ovarian androgen generation: increased peripheral 5α-reductase activity in women with polycystic ovary syndrome J Clin Endocrinol Metab 2003, 88: 2760-2766 (Pubitemid 36724453)
35. Westerbacka J, Yki-Järvinen H, Vehkavaara S, et al. Body fat distribution and cortisol metabolism in healthy men: enhanced 5β-reductase and lower cortisol/cortisone metabolite ratios in men with fatty liver. J Clin Endocrinol Metab 2003, 88: 4924-4931 (Pubitemid 37357545)
36. Livingstone DEW, McInnes KJ, Walker BR, Andrew R. Increased A-ring reduction of glucocorticoids in obese Zucker rats: effects of insulin sensitization. Obes Res 2005, 13: 1523-1526
37. Stenberg A. On the modulating effects of ovaries on neonatal androgen programming of rat liver enzymes. Acta Endocrinol 1975, 78: 294-301.
38. Rosenfield RL. Ovarian and adrenal function in polycystic ovary syndrome. Endocrinol Metab Clin North Am 1999, 28: 265-293 (Pubitemid 29242714)
39. Moghetti P, Castello R, Negri C, et al. Insulin infusion amplifies 17α-hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women: apparent relative impairment of 17,20-lyase activity. J Clin Endocrinol Metab 1996, 81: 881-886 (Pubitemid 26083940)
40. Nestler JE, McClanahan MA, Clore JN, Blackard WG. Insulin inhibits adrenal 17,20-lyase activity in man. J Clin Endocrinol Metab 1992, 74: 362-367